|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 射血分数保留的心力衰竭患者服用螺内酯治疗难治性高血压的效果显示文摘最近的研究表明,醛固酮受体拮抗剂螺内酯应作为治疗难治性高血压(resistant hypertension,RHTN)优选的第四线抗高血压药物。目前螺内酯是否能改善射血分数保留的心力衰竭(heart failure with preserved ejection fraction,HFpEF)和RHTN患者的血压控制情况尚不清楚。 | Rossignol P Claggett BL Liu J Vardeny O Pitt B Zannad F Solomon S 陈云(编译) 叶鹏(审校) | 2019 | 中华高血压杂志2019，0，3： | 5 |
| 2 | Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis显示文摘 | Laurent Calvier Maria Miana Pascal Reboul Victoria Cachofeiro Ernesto Martinez-Martinez Rudolf A. de Boer Fran?oise Poirier Patrick Lacolley Faiez Zannad Patrick Rossignol Natalia López-Andrés | 2013 | Arteriosclerosis, Thrombosis, and Vascular Biology2013，，1： | 2 |
| 3 | Antiarrhythmic Effect of Statin Therapy and Atrial Fibrillation显示文摘 | Laurent Fauchier Bertrand Pierre Axel de Labriolle Caroline Grimard Noura Zannad Dominique Babuty | 2008 | Journal of the American College of Cardiology2008，，8： | 2 |
| 4 | Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure:insights from the randomized aldactone evaluation study (RALES)显示文摘 | Zannad F Alla F Dousset B | 2000 | Circulation2000，102，11： | 1 |
| 5 | Eplerenone,a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction 显示文摘 | PITT B REMME W ZANNAD F | 2003 | N Eng J Med2003，348，14： | 1 |
| 6 | Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure:insights from the randomized aldactone evaluation study (RALES)显示文摘 | Zannad F Alla F Dousset B | 2000 | Circulation2000，102，22： | 1 |
| 7 | The effect of spironolactone on morbidity and mortality in patients with sever heart failure : Randomized Aldactone Evaluation Study Investigators 显示文摘 | Pitt B Zannad F Remme WJ | 1999 | N Engl J Med1999，341，10： | 1 |
| 8 | Eplerenone,a selective aldosterone blocker,in patients with left ventricular dysfunction after myocardial infarction显示文摘 | Pitt B Remme W Zannad F | 2003 | N Engl J Med2003，348，： | 1 |
| 9 | Eplerenone,a selective aldosterone blocker,in patients with left ventricular dysfunction after myocardial infarction显示文摘 | Pitt B Remme W Zannad F | 2003 | N Engl J Med2003，348，14： | 1 |
| 10 | Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction:integrating evidence into clinical practice显示文摘 | Zannad F Gattis Stough W Rossignol P | 2012 | Eur Heart J2012，33，22： | 1 |
| 11 | The effect of spironolactone on Morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators 显示文摘 | Pitt B Zannad F Remme W J | 1999 | N Engl J Med1999，341，10： | 1 |
| 12 | Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction显示文摘 | Pitt B Remme W Zannad F | 2003 | N Eng J Med2003，348，14： | 1 |
| 13 | Risk stratification in cardiovascular disease primary prevention - scoring systems, no- vel markers, and imaging techniques 显示文摘 | Zannad F De Backer G Graham I | 2012 | Fundam Clin Pharma- col2012，26，2： | 1 |
| 14 | Rationale and design of a randomized,double-blind,event-driven,multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death,myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure:the COMMANDER HF trial显示文摘 | Zannad F Greenberg B Cleland JG | 2015 | Eur J Heart Fail2015，17，7： | 1 |
| 15 | Eplemone,a selective aldoste-rone blocker, in patients with leftventricular dysfunction after rmyocardial infarcttion显示文摘 | Pitt B Remme W Zannad F | 2003 | N Engl J Med2003，348，14： | 1 |
| 16 | Trough/peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists显示文摘 | Zannad F Matzinger A Larché J | 1996 | Hypertens1996，9，7： | 1 |
| 17 | for the Randomized Aldactone Evaluation Study:The effect of spironolactone on morbidity and mortality in patients with severe heart failure显示文摘 | Pitt B Zannad F Remme WJ | 1999 | N Engl J Med1999，341，10： | 1 |
| 18 | Insights from the Randomized Aldactone E- valuation Study (RALES) 显示文摘 | Zannad F Alia F Dousset B et ah Limitation of excessive extracellular ma- trix turnover may contribute to survival benefit of spironolactone therapy in pa- tients with congestive heart failure | 2000 | Circulation2000，102，： | 1 |
| 19 | Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach显示文摘 | Jean-Jacques Mourad Bernard Waeber Fa?ez Zannad Maurice Laville Gérard Duru Michel Andréjak | 2004 | Journal of Hypertension2004，，12： | 1 |
| 20 | A selective aldoaterone bloneker in patients with left ventrieular dysfunction after myocardial infarction显示文摘 | Pitt B Remme W J Zannad F | 2003 | N Engl J Med2003，348，14： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员